oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting]
- RxCUI
- 1001066
- RxNorm name
- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting]
- Display name
- SINEX LONG-ACTING (Nasal)
- Full name
- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting]
- Term type
- SBD
- Status
- Active
- Strength
- 0.05%
- Dose form
- Spray
- Route
- Nasal
- Updated
- 2026-10-27 17:45:48
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| oxymetazoline hydrochloride | 0.5 MG / 1 ML | oxymetazoline | oxymetazoline hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Nasal Spray | 126542 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| oxymetazoline | 7812 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Sinex Long-Acting 0.5 MG/ML Nasal Spray | 1 | NAMES |
| RxNorm Name | oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting] | 1 | NAMES |
| RxNorm Synonym | 4 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 3 | CODES | |
| RxCUI | 1001066 | 1 | CODES |
| MMSL_CODE | BD4399 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 64336-170-01 | 64336-170 | Vicks Sinex Severe Oxymetazoline Hydrochloride | Procter & Gamble Manufacturing GmbH | M012 |
| 64336-171-01 | 64336-171 | Vicks Sinex SEVERE Oxymetazoline Hydrochloride | Procter & Gamble Manufacturing GmbH, | M012 |
| 64336-171-02 | 64336-171 | Vicks Sinex SEVERE Oxymetazoline Hydrochloride | Procter & Gamble Manufacturing GmbH, | M012 |
| 64336-173-01 | 64336-173 | Vicks Sinex SEVERE Oxymetazoline Hydrochloride | Procter & Gamble Manufacturing GmbH | M012 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks Sinex SEVERE ORIGINAL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH, | cfd43b8f-8064-6b88-e053-2a95a90a329e | 2026-04-22 | Warnings | 64336-171-02 64336-171-01 64336-171 64336017101 64336017102 1001066 |
| Vicks Sinex Severe Original | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | cfd048c9-2f33-101d-e053-2995a90ad854 | 2026-04-22 | Warnings | 64336-170-01 64336-170 64336017001 1001066 |
| Vicks Sinex SEVERE VapoCOOL ULTRA FINE MIST | OXYMETAZOLINE HYDROCHLORIDE | Procter & Gamble Manufacturing GmbH | d0768332-7c24-7c30-e053-2a95a90a26d4 | 2026-04-22 | Warnings | 64336-173-01 64336-173 64336017301 1001066 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cfd43b8f-8064-6b88-e053-2a95a90a329e | Vicks Sinex 12Hr Decongestant 0.05 % Nasal Spray [PSN] · oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting] [SBD] · Sinex Long-Acting 0.5 MG/ML Nasal Spray [SY] · Vicks Sinex 12-HR Decongestant 0.05 % Nasal Spray [SY] · Vicks Sinex 12-HR Ultra Fine Moisturizing 0.05 % Nasal Spray [SY] · Vicks Sinex Long-Acting 0.05 % Nasal Spray [SY] | 6 | 9 | Vicks ® Sinex™ SEVERE Oxymetazoline HCl | Nasal Decongestant ORIGINAL ULTRA FINE MIST | 20260422 |
| d0768332-7c24-7c30-e053-2a95a90a26d4 | Vicks Sinex 12Hr Decongestant 0.05 % Nasal Spray [PSN] · oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting] [SBD] · Sinex Long-Acting 0.5 MG/ML Nasal Spray [SY] · Vicks Sinex 12-HR Decongestant 0.05 % Nasal Spray [SY] · Vicks Sinex 12-HR Ultra Fine Moisturizing 0.05 % Nasal Spray [SY] · Vicks Sinex Long-Acting 0.05 % Nasal Spray [SY] | 6 | 9 | Vicks ® Severe Sinex™ VapoCOOL CONGESTION RELIEF | 20260422 |
| cfd048c9-2f33-101d-e053-2995a90ad854 | Vicks Sinex 12Hr Decongestant 0.05 % Nasal Spray [PSN] · oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray [Sinex Long-Acting] [SBD] · Sinex Long-Acting 0.5 MG/ML Nasal Spray [SY] · Vicks Sinex 12-HR Decongestant 0.05 % Nasal Spray [SY] · Vicks Sinex 12-HR Ultra Fine Moisturizing 0.05 % Nasal Spray [SY] · Vicks Sinex Long-Acting 0.05 % Nasal Spray [SY] | 6 | 8 | Vicks ® Sinex™ Severe Original Nasal Spray | 20260422 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| d0768332-7c24-7c30-e053-2a95a90a26d4 | Vicks ® Severe Sinex™ VapoCOOL CONGESTION RELIEF | Procter & Gamble Manufacturing GmbH | 20260422 |
| cfd43b8f-8064-6b88-e053-2a95a90a329e | Vicks ® Sinex™ SEVERE Oxymetazoline HCl | Nasal Decongestant ORIGINAL ULTRA FINE MIST | Procter & Gamble Manufacturing GmbH, | 20260422 |
| cfd048c9-2f33-101d-e053-2995a90ad854 | Vicks ® Sinex™ Severe Original Nasal Spray | Procter & Gamble Manufacturing GmbH | 20260422 |
| cfd048c9-2f33-101d-e053-2995a90ad854 | Vicks ® Sinex™ Severe Original Nasal Spray | Procter & Gamble Manufacturing GmbH | 20251210 |
| d0768332-7c24-7c30-e053-2a95a90a26d4 | Vicks ® Severe Sinex™ VapoCOOL CONGESTION RELIEF | Procter & Gamble Manufacturing GmbH | 20251203 |
| cfd43b8f-8064-6b88-e053-2a95a90a329e | Vicks ® Sinex™ SEVERE Oxymetazoline HCl | Nasal Decongestant ORIGINAL ULTRA FINE MIST | Procter & Gamble Manufacturing GmbH, | 20251203 |
| cfd43b8f-8064-6b88-e053-2a95a90a329e | Vicks ® Sinex™ SEVERE Oxymetazoline HCl | Nasal Decongestant ORIGINAL ULTRA FINE MIST | Procter & Gamble Manufacturing GmbH, | 20251001 |
| d0768332-7c24-7c30-e053-2a95a90a26d4 | Vicks ® Severe Sinex™ VapoCOOL CONGESTION RELIEF | Procter & Gamble Manufacturing GmbH | 20251001 |
| cfd048c9-2f33-101d-e053-2995a90ad854 | Vicks ® Sinex™ Severe Original Nasal Spray | Procter & Gamble Manufacturing GmbH | 20251001 |
| 8aa95112-c538-4a55-ab40-ad164d752dd4 | Vicks ® Sinex™ SEVERE MOISTURIZING ULTRA FINE MIST | The Procter & Gamble Manufacturing Company | 20231016 |
| a3503f25-c158-478b-87c6-b218961aa5f2 | Vicks ®Sinex™ SEVERE Oxymetazoline HCl | Nasal Decongestant ORIGINAL ULTRA FINE MIST | The Procter & Gamble Manufacturing Company | 20231016 |
| 7d50b4d8-1f92-7898-e053-2a91aa0a241d | Vicks ® Sinex™ Severe Original Nasal Spray | The Procter & Gamble Manufacturing Company | 20231016 |
| facaea70-28aa-7a9d-e053-6394a90aa5bf | Vicks ® Severe Sinex™ VapoCOOL 12 HOUR DECONGESTANT ULTRA FINE MIST | The Procter & Gamble Manufacturing Company | 20231016 |
| 6f2b46cd-59c5-4196-e053-2991aa0a61cb | Vicks ® Sinex™ Severe No Drip Nasal Spray | The Procter & Gamble Manufacturing Company | 20221209 |
| cfe0e0a6-cec8-b027-e053-2995a90a96aa | Vicks ® Sinex™ Moisturizing | Procter & Gamble Manufacturing GmbH | 20221207 |
| 6e736035-eb66-412f-9b23-b6f490ffdb2c | Vicks ® Sinex™ Scent Free | The Procter & Gamble Manufacturing Company | 20191216 |
| 6d8ee14e-570f-4be6-8231-7bde6d823914 | Vicks ® Sinex™ SEVERE Nasal Spray | The Procter & Gamble Manufacturing Company | 20190625 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | D11AX | Other dermatologicals | ATC1-4 | oxymetazoline | |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | oxymetazoline | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | oxymetazoline | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | oxymetazoline | |
| FDASPL | D048288 | Imidazolines | CHEM | has_chemical_structure | oxymetazoline |
| FDASPL | N0000192562 | Vasoconstrictor | EPC | has_epc | oxymetazoline |
| FDASPL | N0000175651 | Increased Sympathetic Activity | PE | has_pe | oxymetazoline |
| FDASPL | N0000009908 | Vasoconstriction | PE | has_pe | oxymetazoline |
| MEDRT | D010109 | Oxymetazoline | CHEM | has_ingredient | oxymetazoline hydrochloride |
| MEDRT | D010109 | Oxymetazoline | CHEM | has_ingredient | oxymetazoline |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | oxymetazoline |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D003231 | Conjunctivitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | oxymetazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | oxymetazoline hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | oxymetazoline |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | oxymetazoline hydrochloride |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | oxymetazoline |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | oxymetazoline hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | oxymetazoline |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | oxymetazoline hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.5 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | Vicks Sinex 12Hr Decongestant 0.05 % Nasal Spray |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |